Werner Meier

Werner was Vice President of Biologics Drug Discovery, Biogen Inc. responsible for developing therapeutic protein drug candidates. Werner guided the design, expression, characterization and development transition of over two dozen novel protein therapeutics that included antibodies and their derivatives, receptor-Ig fusion proteins and bispecific antibodies.
He is Former Program Director for two development programs aimed at treating immunologic and neurological diseases and successfully guided the programs through preclinical development and manufacturing into early clinical studies. Scientific board member of Applied BioMath and the Institute for Protein Innovation.